ORIGINAL RESEARCH
Accepted on 15 Apr 2025
Frequency of Microsatellite Instability in Gynecologic Cancers and the Efficacy of Immune Checkpoint Inhibitors Treated: Real-World Data from a Single Gynecologic Center
doi 10.3389/fimmu.2025.1567824
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunological Aspects and Immunotherapy in Gynecologic Cancers
Immunological Aspects and Immunotherapy in Gynecologic Cancers
847
Total downloads
5,275
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 15 Apr 2025
Immune checkpoint inhibitor outcomes and prognostic factors in gynecologic tract melanoma: a single-center analysis
doi 10.3389/fimmu.2025.1542293
- 192 views
REVIEW
Accepted on 14 Apr 2025
Unveiling Drug Resistance Pathways in High-Grade Serous Ovarian Cancer(HGSOC): Recent Advances and Future Perspectives
doi 10.3389/fimmu.2025.1556377
- 141 views
REVIEW
Published on 11 Apr 2025
Immunotherapy in gestational trophoblastic neoplasia: advances and future directions
doi 10.3389/fimmu.2025.1544585
- 211 views
ORIGINAL RESEARCH
Published on 09 Apr 2025
Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis
doi 10.3389/fimmu.2025.1537785
- 280 views
OPINION
Published on 08 Apr 2025
Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized strategies and emerging therapies
doi 10.3389/fimmu.2025.1567296
- 279 views
CASE REPORT
Published on 07 Apr 2025
Both complete response and long-term survival after combination therapy with toripalimab in a patient with meta-oligometastases cervical cancer: a case report
doi 10.3389/fimmu.2025.1542795
- 341 views
ORIGINAL RESEARCH
Published on 03 Apr 2025
Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis
doi 10.3389/fimmu.2025.1562875
- 564 views
ORIGINAL RESEARCH
Published on 21 Feb 2025
Analysis of the efficacy and safety of camrelizumab combined with chemotherapy for cervical cancer treatment
doi 10.3389/fonc.2025.1502701
- 567 views
ORIGINAL RESEARCH
Published on 07 Feb 2025
GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer
doi 10.3389/fimmu.2025.1512086
- 886 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: